androstenedione has been researched along with toremifene in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, AM; Goss, PE; Hu, H; Qi, S | 1 |
| Brodie, A; Goloubeva, O; Macedo, L; Sabnis, GJ; Schayowitz, A; Zhu, Y | 1 |
| Blanchett, D; Bondarenko, IN; Goss, P; Langecker, P; Manikhas, GN; Miller, WH; Pendergrass, KB | 1 |
| Goss, PE; Hu, H; Qi, S | 1 |
| Botrè, F; Braganò, MC; de la Torre, X; Mazzarino, M; Molaioni, F | 1 |
1 trial(s) available for androstenedione and toremifene
| Article | Year |
|---|---|
Phase III, double-blind, controlled trial of atamestane plus toremifene compared with letrozole in postmenopausal women with advanced receptor-positive breast cancer.
Topics: Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptors, Steroid; Toremifene; Triazoles | 2007 |
4 other study(ies) available for androstenedione and toremifene
| Article | Year |
|---|---|
The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model.
Topics: Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Disease Models, Animal; Female; Humans; Letrozole; Lipids; Models, Chemical; Nitriles; Organ Size; Ovariectomy; Rats; Rats, Sprague-Dawley; Toremifene; Triazoles; Uterus | 2007 |
Toremifene-atamestane; alone or in combination: predictions from the preclinical intratumoral aromatase model.
Topics: Androstenedione; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Breast Neoplasms; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Mice; Mice, SCID; Prognosis; Toremifene; Transfection; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2008 |
Comparing the effects of atamestane, toremifene and tamoxifen alone and in combination, on bone, serum lipids and uterus in ovariectomized rats.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Body Weight; Bone Density; Bone Density Conservation Agents; Clinical Trials as Topic; Compressive Strength; Epithelial Cells; Estrogen Antagonists; Female; Femur; Humans; Lipids; Lumbar Vertebrae; Ovariectomy; Rats; Rats, Sprague-Dawley; Stress, Mechanical; Tamoxifen; Toremifene; Uterus | 2009 |
Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses.
Topics: Administration, Oral; Adult; Androgens; Androstenedione; Biomarkers; Clomiphene; Doping in Sports; Epitestosterone; Female; Humans; Male; Performance-Enhancing Substances; Reference Standards; Selective Estrogen Receptor Modulators; Sex Factors; Substance Abuse Detection; Tamoxifen; Testosterone; Toremifene | 2011 |